96192 ⎘
Compounds containing elements of Groups 5 or 15 of the Periodic System; Phosphorus compounds; Heterocyclic compounds, e.g. containing phosphorus as a ring hetero atom having nitrogen and oxygen atoms as the only ring hetero atoms; Five-membered rings condensed with carbocyclic rings or carbocyclic ring systems
THIOL-CONJUGATION WITH UNSATURATED PHOSPHORUS(V) COMPOUNDS
#2COMPOUNDS, COMPOSITIONS AND METHODS FOR STABILIZING TRANSTHYRETIN AND INHIBITING TRANSTHYRETIN MISFOLDING
#3Compounds and method for treating autoimmune diseases
#4Substituted tricyclic heterocyclic compounds
#5Heterocyclic bridged biphenyls
#6Compounds and method for treating autoimmune diseases
#7Synthesis of Phosphoramidates
#8Novel Fluorescent Dyes, Labeled Conjugates and Analytical Methods
#9Compounds and method for treating autoimmune diseases
#10Fluorescent dyes, labeled conjugates and analytical methods
#11COMPOUNDS AND METHOD FOR TREATING AUTOIMMUNE DISEASES
#12Copper(I) complexes, in particular for optoelectronic components
#13Phosphate Derivatives of Substituted Benzoxazoles
#14FLUORINATED LIPIDS AND METHODS OF USE
#15Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
#16Substituted arylsulfonylaminomethylphosphonic acid derivatives, their preparation and their use in the treatment of type I and II diabetes mellitus
#17Substituted phosphonates and their use in decreasing amyloid aggregates
#18Mitochondria-targeted antioxidant prodrugs and methods of use
#19New Heterocyclic bridged biphenyls
#20Optically detectable organophosphonates
#21Fluorescent Labeled Sphingosines
#22Non-natural sphingolipid analogs and uses thereof
#23Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#24Novel Heteroaromatic Inhibitors of Fructose-1,6-Bisphosphatase
#25Substituted phosphonate fluorescent sensors and use thereof
#26Amine-substituted biphenyldiphosphines
#27Optically detectable organophosphonates
#28Hybrid phosphoinositide phospholipids: compositions and uses
#29Oxazoline ligands for asymmetric catalysis